Demystifying Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
Identification of the appropriate target is a major part of drug discovery and development, as it is the starting point for drug design and optimization.
Antibody-drug conjugates (ADCs) are therapeutic agents that consist of monoclonal antibodies that are linked to a small-molecule drug or a cytotoxic...
Brentuximab Vedotin works by targeting and binding to a protein known as CD30 on cancer cells.
Therapeutic drug discovery is an interdisciplinary approach to the development of new medicines.